PETS PETMED EXPRESS INC

Nasdaq 1800petmeds.com


$ 2.72 $ -0.01 (-0.36 %)    

Friday, 24-Oct-2025 15:59:16 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 2.74
$ 2.80
$ 2.65 x 80
$ 2.91 x 20
$ 2.70 - $ 2.90
$ 2.42 - $ 6.85
90,233
na
57.58M
$ 0.71
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-14-2025 03-31-2025 10-K
2 02-10-2025 12-31-2024 10-Q
3 11-07-2024 09-30-2024 10-Q
4 08-07-2024 06-30-2024 10-Q
5 06-14-2024 03-31-2024 10-K
6 04-15-2024 12-31-2023 10-Q
7 10-31-2023 09-30-2023 10-Q
8 08-01-2023 06-30-2023 10-Q
9 05-23-2023 03-31-2023 10-K
10 02-07-2023 12-31-2022 10-Q
11 11-08-2022 09-30-2022 10-Q
12 08-02-2022 06-30-2022 10-Q
13 05-24-2022 03-31-2022 10-K
14 02-04-2022 12-31-2021 10-Q
15 11-02-2021 09-30-2021 10-Q
16 07-30-2021 06-30-2021 10-Q
17 05-25-2021 03-31-2021 10-K
18 01-26-2021 12-31-2020 10-Q
19 11-03-2020 09-30-2020 10-Q
20 08-03-2020 06-30-2020 10-Q
21 05-26-2020 03-31-2020 10-K
22 01-28-2020 12-31-2019 10-Q
23 10-30-2019 09-30-2019 10-Q
24 07-30-2019 06-30-2019 10-Q
25 05-28-2019 03-31-2019 10-K
26 01-29-2019 12-31-2018 10-Q
27 10-30-2018 09-30-2018 10-Q
28 07-31-2018 06-30-2018 10-Q
29 05-29-2018 03-31-2018 10-K
30 01-30-2018 12-31-2017 10-Q
31 10-31-2017 09-30-2017 10-Q
32 07-31-2017 06-30-2017 10-Q
33 05-23-2017 03-31-2017 10-K
34 01-31-2017 12-31-2016 10-Q
35 11-01-2016 09-30-2016 10-Q
36 08-01-2016 06-30-2016 10-Q
37 05-24-2016 03-31-2016 10-K
38 02-02-2016 12-31-2015 10-Q
39 10-27-2015 09-30-2015 10-Q
40 07-28-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 petmed-express-announces-that-its-ceo-sandra-campos-and-cfo-robyn-delia-have-resigned-leslie-cg-campbell-has-been-appointed-interim-ceo-and-douglas-krulik-has-been-appointed-interim-principal-financial-officer

PetMed Express, Inc. (the "Company") dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced that its...

 petmed-express-receives-notification-of-deficiency-from-nasdaq

PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS) received on July 2, 2025, an expected notice (the "Notice") fro...

 petmed-express-sees-q4-net-sales-of-511m-531m-and-net-loss-of-99m-104m-sees-fy25-net-sales-of-2316m-2336m-with-net-loss-of-45m-50m

Preliminary Fourth Quarter and FY 2025 Results:For the fiscal fourth quarter ended March 31, 2025, net sales are estimated to r...

 earnings-preview-petmed-express
Earnings Preview: PetMed Express
06/13/2025 14:01:38

 silvercape-investments-says-intends-to-engage-in-discussions-with-petmed-express-management-andor-cos-board-it-may-also-discuss-possibility-of-nominating-person-to-become-director-of-petmed-express

The Reporting Persons have been an investor in the Issuer since February 2025 and hold the Common Stock for investment purposes...

 petmed-express-13g-filing-shows-silvercape-investments-reported-a-111-stake-in-the-co-as-of-may-18-2025

- SEC Filing

 morgan-stanley-maintains-underweight-on-petmed-express-lowers-price-target-to-32

Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION